Table 2.
AL | Sex | Age-specific rate | 0 - 14y | ASIRw 0-14 | 0 - 19y | ASIRw 0 -19 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 - 4 | 5 - 9 | 10 - 14 | 15 - 19 | ||||||||||||
n | cIR | n | cIR | n | cIR | n | cIR | n | cIR | n | cIR | ||||
All-AL | Male | 52 | 47.77 | 63 | 56.26 | 71 | 62.39 | 29 | 25.84 | 185 | 55.40 | 55.28 | 215 | 48.11 | 48.17 |
Female | 57 | 54.26 | 43 | 39.77 | 53 | 48.01 | 20 | 18.17 | 153 | 47.29 | 47.39 | 173 | 39.90 | 40.24 | |
Total | 109 | 50.96 | 106 | 106.00 | 124 | 55.31 | 49 | 22.04 | 338 | 51.35 | 51.46 | 388 | 44.07 | 44.26 | |
Subtype | |||||||||||||||
ALL | Male | 48 | 44.10 | 52 | 46.44 | 56 | 49.21 | 26 | 23.17 | 156 | 46.56 | 46.62 | 182 | 40.73 | 40.83 |
Female | 47 | 44.74 | 35 | 32.37 | 35 | 31.71 | 18 | 16.35 | 117 | 36.16 | 36.34 | 135 | 31.13 | 31.45 | |
Total | 95 | 44.41 | 87 | 87.00 | 91 | 40.59 | 44 | 19.79 | 273 | 41.48 | 41.53 | 317 | 36.00 | 36.21 | |
AML | Male | 4 | 3.67 | 11 | 9.82 | 14 | 12.30 | 3 | 2.67 | 29 | 8.56 | 8.37 | 32 | 7.16 | 7.12 |
Female | 9 | 8.57 | 8 | 7.40 | 16 | 14.49 | 2 | 1.82 | 33 | 10.20 | 10.13 | 35 | 8.07 | 8.10 | |
Total | 13 | 6.08 | 19 | 19.00 | 30 | 13.38 | 5 | 2.25 | 62 | 9.27 | 9.33 | 67 | 7.61 | 7.60 | |
Other | Male | 0 | –––– | 0 | ––– | 1 | 0.88 | 0 | ––– | 1 | 0.29 | 0.30 | 1 | 0.22 | 0.22 |
Female | 1 | 0.95 | 0 | ––– | 2 | 1.81 | 0 | ––– | 3 | 0.93 | 0.92 | 3 | 0.69 | 0.69 | |
Total | 1 | 0.47 | 0 | ––– | 3 | 1.34 | 0 | ––– | 4 | 0.61 | 0.60 | 4 | 0.45 | 0.45 | |
Immunophenotype | |||||||||||||||
B-cell | Male | 46 | 42.26 | 49 | 43.76 | 52 | 45.69 | 25 | 22.28 | 147 | 43.89 | 43.93 | 172 | 38.49 | 38.60 |
Female | 47 | 44.74 | 35 | 32.37 | 31 | 28.08 | 17 | 15.45 | 113 | 34.92 | 35.15 | 130 | 29.98 | 30.33 | |
Total | 93 | 43.48 | 84 | 84.00 | 83 | 37.02 | 42 | 18.89 | 260 | 39.50 | 39.59 | 302 | 34.30 | 34.53 | |
T-cell | Male | 2 | 1.84 | 3 | 2.68 | 3 | 2.64 | 1 | 0.89 | 8 | 2.38 | 2.39 | 9 | 2.01 | 2.02 |
Female | 0 | 0.00 | 0 | 0.00 | 4 | 3.62 | 1 | 0.91 | 4 | 1.24 | 1.19 | 5 | 1.15 | 1.12 | |
Total | 2 | 0.94 | 3 | 3.00 | 7 | 3.12 | 2 | 0.90 | 12 | 1.82 | 1.80 | 14 | 1.59 | 1.58 | |
ALAL | Male | 0 | ––– | 0 | ––– | 1 | 0.88 | 0 | ––– | 1 | 0.30 | 0.29 | 1 | 0.22 | 0.22 |
Female | 0 | ––– | 0 | ––– | 0 | ––– | 0 | ––– | 0 | — | ––– | 0 | ––– | ––– | |
Total | 0 | ––– | 0 | ––– | 1 | 0.45 | 0 | ––– | 1 | 0.15 | 0.15 | 1 | 0.11 | 0.11 |
AL, acute leukemia; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; ALAL, acute leukemias of ambiguous lineage.